Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Johnson & Johnson applies to acquire Pfizer Inc

Media Release

Issued 5 October 2006/049

Johnson & Johnson applies for clearance to acquire Pfizer Inc.

The Commission has received an application from Johnson & Johnson (J&J) to acquire the stock, assets and business of the Consumer Healthcare division of Pfizer Inc.

This is a global acquisition. In New Zealand both parties supply a broad range of pharmaceutical and personal care products.

J&J is listed on the New York Stock Exchange. Its activities are divided into three business segments: consumer; pharmaceutical; and medical devices and diagnostics. In New Zealand, the consumer and medical devices businesses are operated by Johnson & Johnson (New Zealand) Limited, a local company, and the pharmaceutical division is operated by Janssen-Cilag Pty Limited, an Australian company.

Pfizer Inc. is listed on the New York, London, Euronext and Swiss stock exchanges. It manufactures and sells drugs for human and animal consumption as well as other consumer healthcare products. In New Zealand Pfizer Inc. operates through Pfizer New Zealand Limited.

In considering the application, the Commission’s role is to determine whether the acquisition has the effect of substantially lessening competition in a market.

A public version of the application will shortly be available on the Commission’s website under Public Registers.

Media contact: Jacqui Martin, Senior Communications Adviser
Phone work (04) 924 3709, mobile 027 524 3709

Commission media releases can be viewed on its web site


© Scoop Media

Business Headlines | Sci-Tech Headlines


Media Mega Merger: StuffMe Hearing Argues Over Moveable Feast

New Zealand's two largest news publishers are appealing against the Commerce Commission's rejection of the proposal to merge their operations. More>>


Approval: Northern Corridor Decision Released

The approval gives the green light to construction of the last link of Auckland’s Western Ring Route, providing an alternative route from South Auckland to the North Shore. More>>


Crown Accounts: $4.1 Billion Surplus

The New Zealand Government has achieved its third fiscal surplus in a row with the Crown accounts for the year ended 30 June 2017 showing an OBEGAL surplus of $4.1 billion, $2.2 billion stronger than last year, Finance Minister Steven Joyce says. More>>


Mycoplasma Bovis: One New Property Tests Positive

The newly identified property... was already under a Restricted Place notice under the Biosecurity Act. More>>

Accounting Scandal: Suspension Of Fuji Xerox From All-Of-Government Contract

General Manager of New Zealand Government Procurement John Ivil says, “FXNZ has been formally suspended from the Print Technology and Associated Services (PTAS) contract and terminated from the Office Supplies contract.” More>>